High-intensity Interval Training Ameliorates Endothelial Dysfunction Through Adropin, Nitric Oxide, MR-proADM, and Copeptin Changes in Overweight Subjects
Overview
Affiliations
Purpose: The purpose of this study was to determine adropin, NO, MR-proADM, and copeptin changes following four different types of high-intensity interval training (HIIT) in men with overweight.
Methods: In the current study, 45 overweight participants were included in the pre-intervention assessments and randomly assigned to the following groups: (1) control, (2) HIIT bike, (3) HIIT short-treadmill, and (4) HIIT long-treadmill groups. The participants were given 10-min sessions of HIIT intervention between 85 and 95% of VO, followed by 1-min inactive recovery at three sessions/week for 8 weeks. Body composition, VO, ultrasound imaging, diabesity-related risk factors, adropin, NO, MR-proADM, and copeptin were also assessed before and following the HIIT interventions.
Results: There was a statistically significant elevation in adropin and NO levels (p < 0.05), while MR-proADM and copeptin were notably more decreased than those of the control group following the 8 weeks of HIIT interventions (p < 0.01). However, no statistically significant decrease was observed in carotid/femoral intima-media thickness (c/f-IMT) values following the 8-week HIIT interventions, while statistically significant reductions were demonstrated in participants who had no atherosclerotic plaque or IMT < 0.9 mm (p < 0.05).
Conclusions: In conclusion, HIIT had a greater effect on IMT remodeling of the femoral artery than of the carotid artery. Decreased MR-proADM and copeptin and increased adropin levels might act as a physiological surrogate of endothelial dysfunction through increased NO-related signaling pathways in participants with overweight following high-intensity interval training.
Role of the Unique Secreted Peptide Adropin in Various Physiological and Disease States.
Hasanpour-Segherlou Z, Butler A, Candelario-Jalil E, Hoh B Biomolecules. 2025; 14(12.
PMID: 39766320 PMC: 11674490. DOI: 10.3390/biom14121613.
Unveiling the multifaceted role of adropin in various diseases (Review).
Chen L, Lu J, Hu J, Gong X Int J Mol Med. 2024; 54(4).
PMID: 39155866 PMC: 11335353. DOI: 10.3892/ijmm.2024.5414.
Wang H, Cheng R, Xie L, Hu F Front Endocrinol (Lausanne). 2024; 14:1294362.
PMID: 38288474 PMC: 10823366. DOI: 10.3389/fendo.2023.1294362.
Stratakis C Hormones (Athens). 2022; 21(4):521-523.
PMID: 36380266 DOI: 10.1007/s42000-022-00418-2.